Back to Search
HAYAT ITANI, MD
MD
Family Medicine Physician
NPI: 1255956066IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
58145(KY)01096958A(IN)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
OTHER
Class of 2020
Research & Publications (11)
Functional characterization of polymorphisms in the kidney enhancer of the human renin gene.
PMID 17158202·Endocrinology·2007
4-observational
Novel potent antagonists of human neuropeptide Y Y5 receptors. Part 3: 7-methoxy-1-hydroxy-1-substituted tetraline derivatives.
PMID 11859006·Bioorg Med Chem Lett·2002
4-observational
Novel potent antagonists of human neuropeptide Y Y5 receptors. Part 2: substituted benzo[a]cycloheptene derivatives.
PMID 11858996·Bioorg Med Chem Lett·2002
8-other
Regulation of renin gene expression by oxidative stress.
PMID 19433777·Hypertension·2009
4-observational
Is peroxisome proliferator-activated receptor-gamma a new "pal" of renin?
PMID 17785627·Hypertension·2007
7-preclinical
New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 3: 7beta-[2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-ethoxyiminoacetamido] cephalosporins bearing 4-[3-(aminoalkyl)-ureido]-1-pyridinium at C-3'.
PMID 15246098·Bioorg Med Chem·2004
8-other
New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 2: Synthesis and structure-activity relationships in the S-3578 series.
PMID 15246097·Bioorg Med Chem·2004
8-other
S-3578, a new broad spectrum parenteral cephalosporin exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Synthesis and structure-activity relationships.
PMID 12546419·J Antibiot (Tokyo)·2002
8-other
Novel potent antagonists of human neuropeptide Y Y5 receptor. Part 1: 2-oxobenzothiazolin-3-acetic acid derivatives.
PMID 11934581·Bioorg Med Chem Lett·2002
8-other
Design, synthesis and biological evaluation of a novel series of potent, orally active adenosine A1 receptor antagonists with high blood-brain barrier permeability.
PMID 11515591·Chem Pharm Bull (Tokyo)·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 811 E PARRISH AVE STE 102-B
OWENSBORO, KY 42303 - Phone
- (270) 688-1009
Quick Facts
- NPI
- 1255956066
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 3
- Years in Practice
- 6
- Publications
- 11
Are you this provider?
Claim Your Profile